The application of response criteria on reporting treatment results in cancer trials
Kurth, K.
Progress in Clinical and Biological Research 359: 49-64; discussion 73-4
1990
ISSN/ISBN: 0361-7742 PMID: 2284297 Document Number: 348615
Document emailed within 1 workday
Related Documents
Bhandari, M.; Guyatt, G.H.; Lochner, H.; Sprague, S.; Tornetta, P. 2002: Application of the Consolidated Standards of Reporting Trials (CONSORT) in the Fracture Care Literature Journal of Bone and Joint Surgery. American Volume 84(3): 485-489Bromhead, H.J.; Goodman, N.W. 1997: CONSORT statement on the reporting standards of clinical trials. Reporting of refusal of consent to take part in clinical trials is still poor Bmj 314(7087): 1126-1127
Arenberg, I.K.; Brandenburg, J.H.; Sauer, R.C.; Kaemmerle, A.W. 1980: Reporting results in Meniere's disease according to the 1972 AAOO criteria: suggestions for standardization Otolaryngologic Clinics of North America 13(4): 681-692
Aureggi, A.; DI Giorgio, A.; Angrisani, A.; Virno, F.; Bolognese, A.; Stipa, V. 1982: Cancer of the rectum and rectosigmoid junction. Results and criteria of choice of surgical treatment (analysis of 563 cases) Minerva Chirurgica 37(7): 611-622
Moher, D. 1998: CONSORT: an evolving tool to help improve the quality of reports of randomized controlled trials. Consolidated Standards of Reporting Trials JAMA 279(18): 1489-1491
Ivers, N.M.; Taljaard, M.; Dixon, S.; Bennett, C.; McRae, A.; Taleban, J.; Skea, Z.; Brehaut, J.C.; Boruch, R.F.; Eccles, M.P.; Grimshaw, J.M.; Weijer, C.; Zwarenstein, M.; Donner, A. 2011: Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8 Bmj 343: D5886
Evans, W.K.; Coyle, D.; Gafni, A.; Walker, H. 2003: Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis Chronic diseases in Canada 24(4): 102-107
Maślanka, K. 1978: Trials of rosette test application for determination of immune response to antigen D from the Rh system in blood donors immunized with human erythrocytes Archivum Immunologiae et Therapiae Experimentalis 26(1-6): 1105-1109
Levi, D.; Tanno, H.; Descalzi, V. 2006: Criteria to hepatitis C treatment response Acta Gastroenterologica Latinoamericana 36(Suppl 1): S50
Martin, D.S.; Stolfi, R.L.; Sawyer, R.C.; Young, C.W. 1985: Application of biochemical modulation with a therapeutically inactive modulating agent in clinical trials of cancer chemotherapy Cancer Treatment Reports 69(4): 421-423
Hammond, E.H.; Flinner, R.L. 1997: Clinically relevant breast cancer reporting: using process measures to improve anatomic pathology reporting Archives of Pathology and Laboratory Medicine 121(11): 1171-1175
Kusaba, H.; Saijo, N. 2000: A summary report of response evaluation criteria in solid tumors (RECIST criteria) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(1): 1-5
Ol'shanskiĭ, M.S.; Korotkikh, N.N. 2013: Immediate and five-year results of application of preoperative oily chemoembolization of rectal arteries in complex treatment of the loco-regional rectal cancer Vestnik Khirurgii Imeni I. I. Grekova 172(1): 34-37
Lusher, J.M. 1984: Assessment of response to treatment and design of clinical trials Progress in Clinical and Biological Research 150: 167-179
Colditz, G.A. 1996: Selenium and cancer prevention. Promising results indicate further trials required JAMA 276(24): 1984-1985
Caban-Holt, A.; Bottiggi, K.; Schmitt, F.A. 2005: Measuring treatment response in Alzheimer's disease clinical trials Geriatrics Suppl: 3-8
Levin, A. 2001: Reporting standards and the transparency of trials Annals of Internal Medicine 134(2): 169-172
Panzer, H. 2000: Improving the conduct and reporting of clinical trials JAMA 283(21): 2787-8; author reply 2789-90
Needleman, I. 1999: CONSORT. Consolidated Standards of Reporting Trials British Dental Journal 186(5): 207
Hreshchyshyn, M.M. 1975: Results of the Gynecologic Oncology Group trials on ovarian cancer: preliminary report National Cancer Institute Monograph 42: 155-165